High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer's disease

Frontiers in Aging Neuroscience

Volumn 5, Issue DEC, 2013, Pages

  Bester, Janette ^a   Buys, Antoinette V ^a   Lipinski, Boguslaw ^b   Kell, Douglas B ^c   Pretorius, Etheresia ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alzheimer's disease; Atomic force microscopy; Erythrocytes; Iron; Scanning electron microscopy

Indexed keywords

FERRITIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTERIAL STIFFNESS; ARTICLE; ATOMIC FORCE MICROSCOPY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COGNITIVE DEFECT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; EARLY DIAGNOSIS; EPILEPSY; ERYTHROCYTE; ERYTHROCYTE STRUCTURE; FEMALE; FERRITIN BLOOD LEVEL; HEART INFARCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERFERRITINEMIA; HYPERTENSION; HYPOTHYROIDISM; IRON OVERLOAD; LABORATORY TEST; MALE; MEDICAL HISTORY; MICROSCOPY; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; ONSET AGE; OSTEOPOROSIS; OUTER MEMBRANE; SCANNING ELECTRON MICROSCOPY; SMOKING; VERY ELDERLY;

EID: 84895793904     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2013.00088     Document Type: Article

References (124)

1. Adams, P. (2008). Management of elevated serum ferritin levels. Gastroenterol. Hepatol. (N.Y.) 4, 333-334.
2. Adams, P. C., Passmore, L., Chakrabarti, S., Reboussin, D. M., Acton, R. T., Barton, J. C., et al. (2006). Liver diseases in the hemochromatosis and iron overload screening study. Clin. Gastroenterol. Hepatol. 4, 918-923; quiz 807. doi: 10.1016/j.cgh.2006.04.013.
3. Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., et al. (2005). Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. Med. 352, 1769-1778. doi: 10.1056/NEJMoa041534.
4. Aisen, P., Enns, C., and Wessling-Resnick, M. (2001). Chemistry and biology of eukaryotic iron metabolism. Int. J. Biochem. Cell Biol. 33, 940-959. doi: 10.1016/S1357-2725(01)00063-2.
5. Anderson, L. J., Holden, S., Davis, B., Prescott, E., Charrier, C. C., Bunce, N. H., et al. (2001). Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur. Heart J. 22, 2171-2179. doi: 10.1053/euhj.2001.2822.
6. Andresdottir, M. B., Sigfusson, N., Sigvaldason, H., and Gudnason, V. (2003). Erythrocyte sedimentation rate, an independent predictor of coronary heart disease in men and women: the Reykjavik Study. Am. J. Epidemiol. 158, 844-851. doi: 10.1093/aje/kwg222.
7. Baines, A. J. (2009). Evolution of spectrin function in cytoskeletal and membrane networks. Biochem. Soc. Trans. 37, 796-803. doi: 10.1042/BST0370796.
8. Barnham, K. J., and Bush, A. I. (2008). Metals in Alzheimer's and Parkinson's diseases. Curr. Opin. Chem. Biol. 12, 222-228. doi: 10.1016/j.cbpa.2008.02.019.
9. Barton, J. C., Barton, J. C., Acton, R. T., So, J., Chan, S., and Adams, P. C. (2012). Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 mug/L at diagnosis. Clin. Gastroenterol. Hepatol. 10, 412-416. doi: 10.1016/j.cgh.2011.11.032.
10. Bartzokis, G., Lu, P. H., Tingus, K., Peters, D. G., Amar, C. P., Tishler, T. A., et al. (2011). Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology 36, 1375-1384. doi: 10.1038/npp.2011.22.
11. Baskurt, O. K., and Meiselman, H. J. (2003). Blood rheology and hemodynamics. Semin. Thromb. Hemost. 29, 435-450. doi: 10.1055/s-2003-44551.
12. Berquand, A. (2011). Quantitative imaging of living biological samples by PeakForce QNM atomic force microscopy. Bruker Application Note 135, 1-10.
13. Brandhagen, D. J., Fairbanks, V. F., and Baldus, W. (2002). Recognition and management of hereditary hemochromatosis. Am. Fam. Physician 65, 853-860.
14. Broadhurst, D., and Kell, D. B. (2006). Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2, 171-196. doi: 10.1007/s11306-006-0037-z.
15. Buys, A. V., Van Rooy, M. J., Soma, P., Van Papendorp, D., Lipinski, B., and Pretorius, E. (2013). Changes in red blood cell membrane structure in type 2 diabetes: a scanning electron and atomic force microscopy study. Cardiovasc. Diabetol. 12:25. doi: 10.1186/1475-2840-12-25.
16. Cai, X., Gao, S., Cai, J., Wu, Y., and Deng, H. (2009). Artesunate induced morphological and mechanical changes of Jurkat cell studied by AFM. Scanning 31, 83-89. doi: 10.1002/sca.20144.
17. Camaschella, C., and Poggiali, E. (2011). Inherited disorders of iron metabolism. Curr. Opin. Pediatr. 23, 14-20. doi: 10.1097/MOP.0b013e3283425591.
18. Carpenter, J. P., Grasso, A. E., Porter, J. B., Shah, F., Dooley, J., and Pennell, D. J. (2013). On myocardial siderosis and left ventricular dysfunction in hemochromatosis. J. Cardiovasc. Magn. Reson. 15:24. doi: 10.1186/1532-429X-15-24.
19. Casadesus, G., Smith, M. A., Zhu, X., Aliev, G., Cash, A. D., Honda, K., et al. (2004). Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. J. Alzheimers Dis. 6, 165-169.
20. Castellani, R. J., Moreira, P. I., Perry, G., and Zhu, X. (2012). The role of iron as a mediator of oxidative stress in Alzheimer disease. Biofactors 38, 133-138. doi: 10.1002/biof.1010.
21. Choi, J., Malakowsky, C. A., Talent, J. M., Conrad, C. C., and Gracy, R. W. (2002). Identification of oxidized plasma proteins in Alzheimer's disease. Biochem. Biophys. Res. Commun. 293, 1566-1570. doi: 10.1016/S0006-291X(02)00420-5.
22. Connor, J. R., Menzies, S. L., St Martin, S. M., and Mufson, E. J. (1992). A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31, 75-83. doi: 10.1002/jnr.490310111.
23. Cook, J. D., Lipschitz, D. A., Miles, L. E., and Finch, C. A. (1974). Serum ferritin as a measure of iron stores in normal subjects. Am. J. Clin. Nutr. 27, 681-687.
24. Copenhaver, W. M., Bunge, R. P., and Bunge, M. B. (1971). Bailey's Textbook of Histology. Baltimore: The Williams and Wilkins Company.
25. Corti, M. C., Gaziano, M., and Hennekens, C. H. (1997). Iron status and risk of cardiovascular disease. Ann. Epidemiol. 7, 62-68. doi: 10.1016/S1047-2797(96)00112-3.
26. Crapper McLachlan, D. R., Dalton, A. J., Kruck, T. P., Bell, M. Y., Smith, W. L., Kalow, W., et al. (1991). Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337, 1304-1308. doi: 10.1016/0140-6736(91)92978-B.
27. Crichton, R. R., Dexter, D. T., and Ward, R. J. (2011). Brain iron metabolism and its perturbation in neurological diseases. J. Neural Transm. 118, 301-314. doi: 10.1007/s00702-010-0470-z.
28. Crownover, B. K., and Covey, C. J. (2013). Hereditary hemochromatosis. Am. Fam. Physician 87, 183-190.
29. Daniels, R. (2010). Delmar's Guide to Laboratory and Diagnostic Tests. 2nd Edn. New York, NY: Clifton Park.
30. Davalos, D., and Akassoglou, K. (2012). Fibrinogen as a key regulator of inflammation in disease. Semin. Immunopathol. 34, 43-62. doi: 10.1007/s00281-011-0290-8.
31. Day, S. M., Duquaine, D., Mundada, L. V., Menon, R. G., Khan, B. V., Rajagopalan, S., et al. (2003). Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. Circulation 107, 2601-2606. doi: 10.1161/01.CIR.0000066910.02844.D0.
32. Derjaguin, B., Muller, V., and Toporov, Y. (1975). Effect of contact deformations on the adhesion of particles. J. Colloid Interf. Sci. 53, 314-326. doi: 10.1016/0021-9797(75)90018-1.
33. De Sole, P., Rossi, C., Chiarpotto, M., Ciasca, G., Bocca, B., Alimonti, A., et al. (2013). Possible relationship between Al/ferritin complex and Alzheimer's disease. Clin. Biochem. 46, 89-93. doi: 10.1016/j.clinbiochem.2012.10.023.
34. Diomedi, M., and Misaggi, G. (2013). Vascular contribution to Alzheimer disease: predictors of rapid progression. CNS Neurol. Disord. Drug Targets 12, 532-537. doi: 10.2174/1871527311312040015.
35. Dufrêne, Y. F., Martínez-Martin, D., Medalsy, I., Alsteens, D., and Müller, D. J. (2013). Multiparametric imaging of biological systems by force-distance curve-based AFM. Nat. Methods 10, 847-854. doi: 10.1038/nmeth.2602.
36. Dulinska, I., Targosz, M., Strojny, W., Lekka, M., Czuba, P., Balwierz, W., et al. (2006). Stiffness of normal and pathological erythrocytes studied by means of atomic force microscopy. J. Biochem. Biophys. Methods 66, 1-11. doi: 10.1016/j.jbbm.2005.11.003.
37. Eltzschig, H. K., and Carmeliet, P. (2011). Hypoxia and inflammation. N. Engl. J. Med. 364, 656-665. doi: 10.1056/NEJMra0910283.
38. Ershova, L. I., Likhovetskaia, Z. M., Kurbanova, G. N., Shcherbinina, S. P., and Gorbunova, N. A. (1998). Pathogenetic aspects of hemolysis and changes of blood rheology in hereditary hemochromatosis. Ter. Arkh. 70, 74-76.
39. Ferro, E., Visalli, G., Civa, R., La Rosa, M. A., Randazzo Papa, G., Baluce, B., et al. (2012). Oxidative damage and genotoxicity biomarkers in transfused and untransfused thalassemic subjects. Free Radic. Biol. Med. 53, 1829-1837. doi: 10.1016/j.freeradbiomed.2012.08.592.
40. Finberg, K. E. (2013). Striking the target in iron overload disorders. J. Clin. Invest. 123, 1424-1427. doi: 10.1172/JCI68889.
41. Friedman, A., Arosio, P., Finazzi, D., Koziorowski, D., and Galazka-Friedman, J. (2011). Ferritin as an important player in neurodegeneration. Parkinsonism Relat. Disord. 17, 423-430. doi: 10.1016/j.parkreldis.2011.03.016.
42. Funke, C., Schneider, S. A., Berg, D., and Kell, D. B. (2013). Genetics and iron in the systems biology of Parkinson's disease and some related disorders. Neurochem. Int. 62, 637-652. doi: 10.1016/j.neuint.2012.11.015.
43. Giambattistelli, F., Bucossi, S., Salustri, C., Panetta, V., Mariani, S., Siotto, M., et al. (2012). Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease. Neurobiol. Aging 33, 1633-1641. doi: 10.1016/j.neurobiolaging.2011.03.005.
44. Goldstein, S., Meyerstein, D., and Czapski, G. (1993). The Fenton reagents. Free Radic. Biol. Med. 15, 435-445. doi: 10.1016/0891-5849(93)90043-T.
45. Gordeuk, V. R., Lovato, L., Barton, J., Vitolins, M., McLaren, G., Acton, R., et al. (2012). Dietary iron intake and serum ferritin concentration in 213 patients homozygous for the HFEC282Y hemochromatosis mutation. Can. J. Gastroenterol. 26, 345-349.
46. Hori, A., Mizoue, T., Kasai, H., Kawai, K., Matsushita, Y., Nanri, A., et al. (2010). Body iron store as a predictor of oxidative DNA damage in healthy men and women. Cancer Sci. 101, 517-522. doi: 10.1111/j.1349-7006.2009.01394.x.
47. Horwitz, L. D., and Rosenthal, E. A. (1999). Iron-mediated cardiovascular injury. Vasc. Med. 4, 93-99. doi: 10.1191/135886399676588477.
48. Jacobs, E. M., Hendriks, J. C., van Deursen, C. T., Kreeftenberg, H. G., de Vries, R. A., Marx, J. J., et al. (2009). Severity of iron overload of proband determines serum ferritin levels in families with HFE-related hemochromatosis: the HEmochromatosis FAmily Study. J. Hepatol. 50, 174-183. doi: 10.1016/j.jhep.2008.08.014.
49. Jin, H., Xing, X., Zhao, H., Chen, Y., Huang, X., Ma, S., et al. (2010). Detection of erythrocytes influenced by aging and type 2 diabetes using atomic force microscope. Biochem. Biophys. Res. Commun. 391, 1698-1702. doi: 10.1016/j.bbrc.2009.12.133.
50. Jomova, K., and Valko, M. (2011). Importance of iron chelation in free radical-induced oxidative stress and human disease. Curr. Pharm. Des. 17, 3460-3473. doi: 10.2174/138161211798072463.
51. Kanwar, P., and Kowdley, K. V. (2013). Diagnosis and treatment of hereditary hemochromatosis: an update. Expert Rev. Gastroenterol. Hepatol. 7, 517-530. doi: 10.1586/17474124.2013.816114.
52. Kell, D. B. (2009). Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med. Genomics 2:2. doi: 10.1186/1755-8794-2-2.
53. Kell, D. B. (2010). Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson's, Huntington's, Alzheimer's, prions, bactericides, chemical toxicology and others as examples. Arch. Toxicol. 84, 825-889. doi: 10.1007/s00204-010-0577-x.
54. Kellner, H., and Zoller, W. G. (1992). Repeated isovolemic large-volume erythrocytapheresis in the treatment of idiopathic hemochromatosis. Z. Gastroenterol. 30, 779-783.
55. Khechaduri, A., Bayeva, M., Chang, H. C., and Ardehali, H. (2013). Heme levels are increased in human failing hearts. J. Am. Coll. Cardiol. 61, 1884-1893. doi: 10.1016/j.jacc.2013.02.012.
56. Kling, M. A., Trojanowski, J. Q., Wolk, D. A., Lee, V. M. A., and Arnold, S. E. (2013). Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimers Dement 9, 76-92. doi: 10.1016/j.jalz.2012.02.007.
57. Kolar, P., Tomankova, K., Malohlava, J., Zapletalova, J., Vujtek, M., Safarova, K., et al. (2013). The effect of photodynamic treatment on the morphological and mechanical properties of the HeLa cell line. Gen. Physiol. Biophys. 32, 337-346. doi: 10.4149/gpb_2013042.
58. Kondur, A. K., Li, T., Vaitkevicius, P., and Afonso, L. (2009). Quantification of myocardial iron overload by cardiovascular magnetic resonance imaging T2* and review of the literature. Clin. Cardiol. 32, E55-E59. doi: 10.1002/clc.20310.
59. Koshino, I., Mohandas, N., and Takakuwa, Y. (2012). Identification of a novel role for dematin in regulating red cell membrane function by modulating spectrin-actin interaction. J. Biol. Chem. 287, 35244-35250. doi: 10.1074/jbc. M111.305441.
60. Kovacic, J. C., and Fuster, V. (2012). Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease. Mt. Sinai J. Med. 79, 664-673. doi: 10.1002/msj.21347.
61. Kowal, P. (1996). Hemorheology in cerebral ischemia. Neurol. Neurochir. Pol. 30(Suppl. 2), 7-11.
62. Koziol, J. A., Ho, N. J., Felitti, V. J., and Beutler, E. (2001). Reference centiles for serum ferritin and percentage of transferrin saturation, with application to mutations of the HFE gene. Clin. Chem. 47, 1804-1810.
63. Kupershmidt, L., Amit, T., Bar-Am, O., Weinreb, O., and Youdim, M. B. (2012a). Multi-target, neuroprotective and neurorestorative M30 improves cognitive impairment and reduces Alzheimer's-like neuropathology and age-related alterations in mice. Mol. Neurobiol. 46, 217-220. doi: 10.1007/s12035-012-8304-7.
64. Kupershmidt, L., Amit, T., Bar-Am, O., Youdim, M. B., and Weinreb, O. (2012b). The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer's disease. Antioxid. Redox Signal. 17, 860-877. doi: 10.1089/ars.2011.4279.
65. Kwan, T., Leber, B., Ahuja, S., Carter, R., and Gerstein, H. C. (1998). Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene. Clin. Invest. Med. 21, 251-257.
66. Lekka, M., Fornal, M., Pyka-Fosciak, G., Lebed, K., Wizner, B., Grodzicki, T., et al. (2005). Erythrocyte stiffness probed using atomic force microscope. Biorheology 42, 307-317.
67. Limdi, J. K., and Crampton, J. R. (2004). Hereditary haemochromatosis. QJM 97, 315-324. doi: 10.1093/qjmed/hch065.
68. Lipinski, B., and Pretorius, E. (2013). Iron-induced fibrin in cardiovascular disease. Curr. Neurovasc. Res. 10, 269-274. doi: 10.2174/15672026113109990016.
69. Lipinski, B., Pretorius, E., Oberholzer, H. M., and van der Spuy, W. J. (2012a). Interaction of fibrin with red blood cells: the role of iron. Ultrastruct. Pathol. 36, 79-84. doi: 10.3109/01913123.2011.627491.
70. Lipinski, B., Pretorius, E., Oberholzer, H. M., and van der Spuy, W. J. (2012b). Iron enhances generation of fibrin fibers in human blood: implications for pathogenesis of stroke. Microsc. Res. Tech. 75, 1185-1190. doi: 10.1002/jemt.22047.
71. Lu, X., Wu, L., Liu, Z., Xie, L., and Wang, S. (2013). Peripheral blood mononuclear cells inhibit proliferation and promote apoptosis of HeLa cells following stimulation with Bacillus Calmette-Guerin. Exp. Ther. Med. 5, 561-566.
72. Maggio, A., Vitrano, A., Calvaruso, G., Barone, R., Rigano, P., Mancuso, L., et al. (2013). Serial echocardiographic left ventricular ejection fraction measurements: a tool for detecting thalassemia major patients at risk of cardiac death. Blood Cells Mol. Dis. 50, 241-246. doi: 10.1016/j.bcmd.2012.12.002.
73. Martines, A. M. F., Masereeuw, R., Tjalsma, H., Hoenderop, J. G., Wetzels, J. F. M., and Swinkels, D. W. (2013). Iron metabolism in the pathogenesis of iron-induced kidney injury. Nat. Rev. Nephrol. 9, 385-398. doi: 10.1038/nrneph.2013.98.
74. McCullen, M. A., Crawford, D. H., and Hickman, P. E. (2002). Screening for hemochromatosis. Clin. Chim. Acta 315, 169-186. doi: 10.1016/S0009-8981(01)00711-2.
75. McMahon, C. J., Hopkins, S., Vail, A., King, A. T., Smith, D., Illingworth, K. J., et al. (2013). Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. J. Neurointerv. Surg. 5, 512-517. doi: 10.1136/neurintsurg-2012-010386.
76. Merkle, D. L., Cheng, C. H., Castellino, F. J., and Chibber, B. A. (1996). Modulation of fibrin assembly and polymerization by the beta-amyloid of Alzheimer's disease. Blood Coagul. Fibrinolysis 7, 650-658. doi: 10.1097/00001721-199609000-00011.
77. Meroño, T., Rosso, L. G., Sorroche, P., Boero, L., Arbelbide, J., and Brites, F. (2011). High risk of cardiovascular disease in iron overload patients. Eur. J. Clin. Invest. 41, 479-486. doi: 10.1111/j.1365-2362.2010.02429.x.
78. Mirijanian, D. T., and Voth, G. A. (2008). Unique elastic properties of the spectrin tetramer as revealed by multiscale coarse-grained modeling. Proc. Natl. Acad. Sci. U.S.A. 105, 1204-1208. doi: 10.1073/pnas.0707500105.
79. Mohandas, N., and Gallagher, P. G. (2008). Red cell membrane: past, present, and future. Blood 112, 3939-3948. doi: 10.1182/blood-2008-07-161166.
80. Mohanty, J. G., Eckley, D. M., Williamson, J. D., Launer, L. J., and Rifkind, J. M. (2008). Do red blood cell-beta-amyloid interactions alter oxygen delivery in Alzheimer's disease? Adv. Exp. Med. Biol. 614, 29-35. doi: 10.1007/978-0-387-74911-2_4.
81. Mohanty, J. G., Shukla, H. D., Williamson, J. D., Launer, L. J., Saxena, S., and Rifkind, J. M. (2010). Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology. Proteome Sci. 8, 11. doi: 10.1186/1477-5956-8-11.
82. Müller, D. J., Helenius, J., Alsteens, D., and Dufreñe, Y. F. (2009). Force probing surfaces of living cells to molecular resolution. Nat. Chem. Biol. 5, 383-390. doi: 10.1038/nchembio.181.
83. Nans, A., Mohandas, N., and Stokes, D. L. (2011). Native ultrastructure of the red cell cytoskeleton by cryo-electron tomography. Biophys. J. 101, 2341-2350. doi: 10.1016/j.bpj.2011.09.050.
84. Noori, N. M., Keshavarz, K., and Shahriar, M. (2012). Cardiac and pulmonary dysfunction in asymptomatic beta-thalassanemia major. Asian Cardiovasc. Thorac. Ann. 20, 555-559. doi: 10.1177/0218492312439706.
85. Orino, K. (2013). Functional binding analysis of human fibrinogen as an iron-and heme-binding protein. Biometals 26, 789-794. doi: 10.1007/s10534-013-9657-8.
86. Paul, J., Strickland, S., and Melchor, J. P. (2007). Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J. Exp. Med. 204, 1999-2008. doi: 10.1084/jem.20070304.
87. Penke, L., Valdés Hernandéz, M. C., Maniega, S. M., Gow, A. J., Murray, C., Starr, J. M., et al. (2012). Brain iron deposits are associated with general cognitive ability and cognitive aging. Neurobiol. Aging 33, 510-517 e512. doi: 10.1016/j.neurobiolaging.2010.04.032.
88. Perfetto, S. P., Chattopadhyay, P. K., Lamoreaux, L., Nguyen, R., Ambrozak, D., Koup, R. A., et al. (2010). Amine-reactive dyes for dead cell discrimination in fixed samples. Curr. Protoc. Cytom. Chapter 9, Unit 9.34. doi: 10.1002/0471142956.cy0934s53.
89. Picas, L., Rico, F., Deforet, M., and Scheuring, S. (2013). Structural and mechanical heterogeneity of the erythrocyte membrane reveals hallmarks of membrane stability. ACS Nano 7, 1054-1063. doi: 10.1021/nn303824j.
90. Pra, D., Franke, S. I., Henriques, J. A., and Fenech, M. (2012). Iron and genome stability: an update. Mutat. Res. 733, 92-99. doi: 10.1016/j.mrfmmm.2012.02.001.
91. Pretorius, E. (2013). The adaptability of red blood cells. Cardiovasc. Diabetol. 12:63. doi: 10.1186/1475-2840-12-63.
92. Pretorius, E., Bester, J., Vermeulen, N., and Lipinski, B. (2013a). Oxidation inhibits iron-induced blood coagulation. Curr. Drug Targets 14, 13-19. doi: 10.2174/138945013804806541.
93. Pretorius, E., du Plooy, J. N., Soma, P., Keyser, I., and Buys, A. V. (2013b). Smoking and fluidity of erythrocyte membranes: a high resolution scanning electron and atomic force microscopy investigation. Nitric oxide 35C, 42-46. doi: 10.1016/j.niox.2013.08.003.
94. Pretorius, E., Vermeulen, N., Bester, J., Lipinski, B., and Kell, D. B. (2013c). A novel method for assessing the role of iron and its functional chelation in fibrin fibril formation: the use of scanning electron microscopy. Toxicol. Mech. Methods 23, 352-359. doi: 10.3109/15376516.2012.762082.
95. Pretorius, E., Bester, J., Vermeulen, N., Lipinski, B., Gericke, G. S., and Kell, D. B. (in press). Profound morphological changes in the erythrocytes and fibrin networks of patients with hemochromatosis or with hyperferritinemia, and their normalization by iron chelators and other agents. PLoS ONE.
96. Pretorius, E., and Lipinski, B. (2013). Iron alters red blood cell morphology. Blood 121, 9. doi: 10.1182/blood-2012-09-454793.
97. Quintana, C., Bellefqih, S., Laval, J. Y., Guerquin-Kern, J. L., Wu, T. D., Avila, J., et al. (2006). Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J. Struct. Biol. 153, 42-54. doi: 10.1016/j.jsb.2005.11.001.
98. Rajapurkar, M. M., Shah, S. V., Lele, S. S., Hegde, U. N., Lensing, S. Y., Gohel, K., et al. (2012). Association of catalytic iron with cardiovascular disease. Am. J. Cardiol. 109, 438-442. doi: 10.1016/j.amjcard.2011.09.032.
99. Reif, D. W. (1992). Ferritin as a source of iron for oxidative damage. Free Radic. Biol. Med. 12, 417-427. doi: 10.1016/0891-5849(92)90091-T.
100. Rival, T., Page, R. M., Chandraratna, D. S., Sendall, T. J., Ryder, E., Liu, B., et al. (2009). Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's disease. Eur. J. Neurosci. 29, 1335-1347. doi: 10.1111/j.1460-9568.2009.06701.x.
101. Robinson, D., Bucci, J., Fenn, H., Miller, T., Tinklenberg, J., and Yesavage, J. A. (1995). Erythrocyte sedimentation rate in Alzheimer's dementia. J. Am. Geriatr. Soc. 43, 1177-1178.
102. Shariat, A., Nazeri, M., Abolhasani Foroughi, A., and Karimi, M. (2013). Transcranial doppler ultrasonography in beta-thalassemia major patients without and with thrombocytosis. Iran. Red Crescent Med. J. 15, 234-238. doi: 10.5812/ircmj.4606.
103. Shin, S., Ku, Y., Babu, N., and Singh, M. (2007). Erythrocyte deformability and its variation in diabetes mellitus. Indian J. Exp. Biol. 45, 121-128.
104. Shizukuda, Y., Bolan, C. D., Nguyen, T. T., Botello, G., Tripodi, D. J., Yau, Y. Y., et al. (2007). Oxidative stress in asymptomatic subjects with hereditary hemochromatosis. Am. J. Hematol. 82, 249-250. doi: 10.1002/ajh.20743.
105. Shizukuda, Y., Bolan, C. D., Tripodi, D. J., Yau, Y. Y., Nguyen, T. T., Botello, G., et al. (2006). Significance of left atrial contractile function in asymptomatic subjects with hereditary hemochromatosis. Am. J. Cardiol. 98, 954-959. doi: 10.1016/j.amjcard.2006.04.040.
106. Smith, M. A., Zhu, X., Tabaton, M., Liu, G., McKeel, D. W. Jr., Cohen, M. L., et al. (2010). Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 19, 363-372. doi: 10.3233/JAD-2010-1239.
107. Starodubtseva, M. N., Kuznetsova, T. G., Yegorenkov, N. I., and Cherenkevich, S. N. (2008). Structural and mechanical characteristics of erythrocyte membranes in patients with type 2 diabetes mellitus. Bull. Exp. Biol. Med. 145, 99-103. doi: 10.1007/s10517-008-0036-3.
108. Stewart, J. C., Villasmil, M. L., and Frampton, M. W. (2007). Changes in fluorescence intensity of selected leukocyte surface markers following fixation. Cytometry A 71, 379-385. doi: 10.1002/cyto.a.20392.
109. Swanepoel, A. C., and Pretorius, E. (2012). Scanning electron microscopy analysis of erythrocytes in thromboembolic ischemic stroke. Int. J. Lab. Hematol. 34, 185-191. doi: 10.1111/j.1751-553X.2011.01379.x.
110. Tateishi, N., Suzuki, Y., Cicha, I., and Maeda, N. (2001). O2 release from erythrocytes flowing in a narrow O2-permeable tube: effects of erythrocyte aggregation. Am. J. Physiol. Heart Circ. Physiol. 281, H448-H456.
111. Torti, F. M., and Torti, S. V. (2002). Regulation of ferritin genes and protein. Blood 99, 3505-3516. doi: 10.1182/blood. V99.10.3505.
112. Tripathy, D., Sanchez, A., Yin, X., Luo, J., Martinez, J., and Grammas, P. (2013). Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia. Front. Aging Neurosci. 5:19. doi: 10.3389/fnagi.2013.00019.
113. Tsuchiya, K., and Nitta, K. (2013). Hepcidin is a potential regulator of iron status in chronic kidney disease. Ther. Apher. Dial. 17, 1-8. doi: 10.1111/1744-9987.12001.
114. Umur, E. E., Oktenli, C., Celik, S., Tangi, F., Sayan, O., Sanisoglu, Y. S., et al. (2011). Increased iron and oxidative stress are separately related to cognitive decline in elderly. Geriatr. Gerontol. Int. 11, 504-509. doi: 10.1111/j.1447-0594.2011.00694.x.
115. Undas, A., and Ariëns, R. A. (2011). Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases. Arterioscler. Thromb. Vasc. Biol. 31, e88-99. doi: 10.1161/ATVBAHA.111.230631.
116. Wang, W., Knovich, M. A., Coffman, L. G., Torti, F. M., and Torti, S. V. (2010). Serum ferritin: past, present and future. Biochim. Biophys. Acta 1800, 760-769. doi: 10.1016/j.bbagen.2010.03.011.
117. Wardman, P., and Candeias, L. P. (1996). Fenton chemistry: an introduction. Radiat. Res. 145, 523-531. doi: 10.2307/3579270.
118. Weinberg, E. D. (2010). The hazards of iron loading. Metallomics 2, 732-740. doi: 10.1039/c0mt00023j.
119. Weisel, J. W. (2005). Fibrinogen and fibrin. Adv. Protein Chem. 70, 247-299. doi: 10.1016/S0065-3233(05)70008-5.
120. Wong, B. (2011). Points of view: the overview figure. Nat. Methods 8:365. doi: 10.1038/nmeth0511-365.
121. Wyss-Coray, T., and Rogers, J. (2012). Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb. Perspect. Med. 2:a006346. doi: 10.1101/cshperspect.a006346.
122. Zacharski, L. R., Shamayeva, G., and Chow, B. K. (2011). Effect of controlled reduction of body iron stores on clinical outcomes in peripheral arterial disease. Am. Heart J. 162, 949-957 e941. doi: 10.1016/j.ahj.2011.08.013.
123. Zegrean, M. (2009). Association of body iron stores with development of cardiovascular disease in the adult population: a systematic review of the literature. Can. J. Cardiovasc. Nurs. 19, 26-32.
124. Zhao, N., Sun, Z., Mao, Y., Hang, P., Jiang, X., Sun, L., et al. (2010). Myocardial iron metabolism in the regulation of cardiovascular diseases in rats. Cell. Physiol. Biochem. 25, 587-594. doi: 10.1159/000315077.